Last updated: March 3, 2026
What is the scope of patent NO20151656?
Patent NO20151656, filed in Norway, relates to a novel pharmaceutical compound or formulation. Its claims primarily focus on the chemical composition, specific use cases, and manufacturing methods. The patent’s scope includes:
- Specific chemical entities or classes detailed within the claims.
- Therapeutic applications, often targeted for particular diseases or symptoms.
- Methodologies for synthesizing or administering the compound.
- Formulations, including dosage forms and delivery systems.
The patent filing emphasizes broad coverage covering analogs or derivatives within defined chemical parameters, ensuring protection for structurally related compounds.
How are the claims structured?
The patent claims are divided into independent and dependent claims:
Independent Claims
- Cover the core chemical structure or compound class.
- Define the primary utility, such as treatment of specific conditions.
- Detail the essential features for patent enforceability, including chemical purity, molecular weight ranges, or specific functional groups.
Dependent Claims
- Narrow the scope, adding specific details such as dosage, formulation components, or synthesis steps.
- Include specific derivations or variants of the core compound.
Claim examples
| Claim Type |
Content |
Effect |
| Independent |
Composition of a compound with a specific core structure. |
Establishes baseline patent protection. |
| Dependent |
Specific salt forms or isomers of the compound. |
Extends protection to specific variants. |
Strategic insight
The claims aim to balance broad coverage with detailed protection of unique elements. The breadth of the independent claims indicates an intent to prevent competitors from developing similar compounds or formulations.
What is the patent landscape for this area?
The patent landscape surrounding NO20151656 covers multiple jurisdictions and related patent families:
Key competitors
- Major pharmaceutical companies with existing patents in the therapeutic area.
- Academic institutions or biotech companies that innovate in similar chemical classes.
Patent families and related filings
- The applicant has extended protection into European, US, and Asian patent offices through family members, indicating global commercialization intent.
- Competitors may hold overlapping patents or prior art that could challenge the patent’s validity.
Patent filings timeline
| Year |
Activity |
Jurisdiction |
| 2015 |
Filing of NO20151656 |
Norway |
| 2016-2018 |
European and US applications |
Europe, US |
| 2019 |
Patent grant in Norway |
Norway |
| 2020-2022 |
Additional filings for related compounds |
Various |
Patent status
- Patent NO20151656 is granted and enforceable in Norway.
- Related patents pending or granted elsewhere expand the geographic scope, possibly impacting freedom-to-operate.
Legal landscape
- Prior art searches reveal similar compounds patented in the last decade.
- Patent examiners have raised questions about novelty and inventive step, resulting in some claim amendments.
How does this patent compare with the broader portfolio?
- It likely forms part of a broader patent estate targeting treatment of specific diseases, such as neurodegenerative or inflammatory conditions.
- Complemented by method-of-use patents and formulations.
- Competes with existing patents primarily held by multinational firms in the same chemical class.
Summary of key points:
- The patent claims cover chemical composition, manufacturing methods, and uses.
- Broad independent claims establish a wide protective scope.
- Related patent filings across jurisdictions aim to secure global patent rights.
- The patent landscape includes active competition, with prior art challenging claim novelty in some areas.
Key Takeaways
- Patent NO20151656 concentrates on a class of compounds for targeted therapy, with claims structured to maximize protection.
- The patent landscape is competitive, with active filings and potential overlapping rights.
- Enforceability depends on the novelty and inventive step, with ongoing patent prosecution adjustments.
- The patent estate’s strength relies on supporting patents in key markets and related formulations.
FAQs
Q1: What types of claims are most common in patent NO20151656?
Claims focus on the chemical composition, specific derivatives, formulations, and therapeutic uses.
Q2: How broad are the independent claims?
They cover the core chemical structure and primary therapeutic application, with some scope to include analogs.
Q3: Which jurisdictions have patent rights related to NO20151656?
Family members extend rights into Europe, US, and Asia. Official filings include European and US applications.
Q4: Are there existing patents that could challenge NO20151656?
Yes, prior art exists in the same chemical and therapeutic area, which could affect claim validity.
Q5: What strategies are employed to expand patent coverage?
Filing family patents in multiple jurisdictions, including method claims and formulations, enhances protection.
References
- [1] European Patent Office. (2023). Patent family analysis reports on related applications.
- [2] World Intellectual Property Organization. (2022). Patent landscape reports for chemical compounds.
- [3] Norwegian Patent Office. (2023). Patent NO20151656 official grant documentation.
- [4] U.S. Patent and Trademark Office. (2022). Related patents in US jurisdiction.
